455 related articles for article (PubMed ID: 9828206)
1. Effect of intraduodenal bile salt on pancreaticobiliary responses to bombesin and to cholecystokinin in humans.
Thimister PW; Hopman WP; Tangerman A; Rosenbusch G; Willems HL; Jansen JB
Hepatology; 1998 Dec; 28(6):1454-60. PubMed ID: 9828206
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of pancreaticobiliary secretion by loperamide in humans.
Thimister PW; Hopman WP; van Roermund RF; Willems HL; Rosenbusch G; Woestenborghs R; Jansen JB
Hepatology; 1997 Aug; 26(2):256-61. PubMed ID: 9252131
[TBL] [Abstract][Full Text] [Related]
3. Exocrine pancreatic secretion and plasma levels of cholecystokinin, pancreatic polypeptide, and somatostatin after single and combined intraduodenal application of different bile salts in man.
Riepl RL; Fiedler F; Kowalski C; Teufel J; Lehnert P
Ital J Gastroenterol; 1996; 28(8):421-9. PubMed ID: 9032583
[TBL] [Abstract][Full Text] [Related]
4. Effect of intraduodenal administration of ursodeoxycholic acid on interdigestive interaction between gallbladder motility, pancreatic secretion and endocrine activity.
Neubrand MW; Dominguez-Munoz JE; Reichel C; Kampmann S; Eschmann K; von Falkenhausen M; Bregulla M; Malfertheiner P; Sauerbruch T
Digestion; 2004; 69(3):149-57. PubMed ID: 15114045
[TBL] [Abstract][Full Text] [Related]
5. Physiological control of cholecystokinin release and pancreatic enzyme secretion by intraduodenal bile acids.
Koop I; Schindler M; Bosshammer A; Scheibner J; Stange E; Koop H
Gut; 1996 Nov; 39(5):661-7. PubMed ID: 9026479
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of cholecystokinin and cholecystokinin octapeptide on pancreatic secretion, gallbladder contraction, and plasma pancreatic polypeptide in man.
Regan PT; Go VL; DiMagno EP
J Lab Clin Med; 1980 Oct; 96(4):743-8. PubMed ID: 7419959
[TBL] [Abstract][Full Text] [Related]
7. Effect of cadmium and bombesin on exocrine pancreatic secretions and plasma levels of gastrin and cholecystokinin (CCK) in rats.
Chowdhury P; Ami M; Rayford PL
Ann Clin Lab Sci; 1986; 16(6):479-87. PubMed ID: 3800302
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cholecystokinin-stimulated pancreaticobiliary output in man by the cholecystokinin receptor antagonist MK-329.
Cantor P; Olsen O; Gertz BJ; Gjorup I; Worning H
Scand J Gastroenterol; 1991 Jun; 26(6):627-37. PubMed ID: 1713709
[TBL] [Abstract][Full Text] [Related]
9. The effect of the cholecystokinin receptor antagonist MK-329 on meal-stimulated pancreaticobiliary output in humans.
Cantor P; Mortensen PE; Myhre J; Gjorup I; Worning H; Stahl E; Survill TT
Gastroenterology; 1992 May; 102(5):1742-51. PubMed ID: 1568584
[TBL] [Abstract][Full Text] [Related]
10. Role of intraduodenal proteases in plasma cholecystokinin and pancreaticobiliary responses to protein and amino acids.
Thimister PW; Hopman WP; Sloots CE; Rosenbusch G; Willems HL; Trijbels FJ; Jansen JB
Gastroenterology; 1996 Feb; 110(2):567-75. PubMed ID: 8566605
[TBL] [Abstract][Full Text] [Related]
11. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.
Hildebrand P; Beglinger C; Gyr K; Jansen JB; Rovati LC; Zuercher M; Lamers CB; Setnikar I; Stalder GA
J Clin Invest; 1990 Mar; 85(3):640-6. PubMed ID: 2312719
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic, gallbladder, and gastric responses to intraduodenal calcium perfusion in man.
Holtermuller KH; Mallagelada JR; McCall JT; Go VL
Gastroenterology; 1976 May; 70(5 PT.1):693-6. PubMed ID: 1261760
[TBL] [Abstract][Full Text] [Related]
13. Effect of intragastric or intraduodenal administration of a polymeric diet on gallbladder motility, small-bowel transit time, and hormone release.
Ledeboer M; Masclee AA; Biemond I; Lamers CB
Am J Gastroenterol; 1998 Nov; 93(11):2089-96. PubMed ID: 9820378
[TBL] [Abstract][Full Text] [Related]
14. Cholestyramine influences meal-stimulated pancreaticobiliary function and plasma cholecystokinin independent of gastric emptying and food digestion.
Thimister PW; Hopman WP; Loualidi A; Rosenbusch G; Willems HL; Trijbels FJ; Jansen JB
Scand J Gastroenterol; 1997 Aug; 32(8):778-84. PubMed ID: 9282969
[TBL] [Abstract][Full Text] [Related]
15. Mediators of exocrine pancreatic secretion induced by intraduodenal application of bile and taurodeoxycholate in man.
Riepl RL; Reichardt B; Rauscher J; Tzavella K; Teufel J; Lehnert P
Eur J Med Res; 1997 Jan; 2(1):23-9. PubMed ID: 9049590
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of a new serine derivative cholecystokinin receptor antagonist TP-680 on pancreatic, biliary and gastric function.
Tachibana I; Kanagawa K; Yamamoto Y; Otsuki M
J Pharmacol Exp Ther; 1996 Dec; 279(3):1404-12. PubMed ID: 8968365
[TBL] [Abstract][Full Text] [Related]
17. Effects of atropine, proglumide, and somatostatin analogue (SMS 201-995) on bombesin-induced gallbladder contraction and CCK secretion in humans.
Mitsukawa T; Takemura J; Nishizono F; Nakatsuru K; Ohgo S; Matsukura S
Am J Gastroenterol; 1989 Nov; 84(11):1371-4. PubMed ID: 2683738
[TBL] [Abstract][Full Text] [Related]
18. Interactions between intraluminal bile acids and digestive products on pancreatic and gallbladder function.
Malagelada JR; Go VL; DiMagno EP; Summerskill WH
J Clin Invest; 1973 Sep; 52(9):2160-5. PubMed ID: 4727454
[TBL] [Abstract][Full Text] [Related]
19. Effect of bile salt binding or protease inactivation on plasma cholecystokinin and gallbladder responses to bombesin.
Thimister PW; Hopman WP; Sloots CE; Rosenbusch G; Tangerman A; Willems HL; Lamers CB; Jansen JB
Gastroenterology; 1994 Dec; 107(6):1627-35. PubMed ID: 7958672
[TBL] [Abstract][Full Text] [Related]
20. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide.
Schmidt WE; Creutzfeldt W; Schleser A; Choudhury AR; Nustede R; Höcker M; Nitsche R; Sostmann H; Rovati LC; Fölsch UR
Am J Physiol; 1991 Feb; 260(2 Pt 1):G197-206. PubMed ID: 1996640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
